Breaking News

Recent Posts

FDA approves new prostate cancer imaging tool, company says

The company behind an imaging agent meant to identify cancer said it received FDA approval on Thursday for use in patients with suspected metastasis or recurrence. Lantheus Holdings, Inc. said its PYLARIFY injection will now be immediately available in parts of the mid-Atlantic and southern regions, with availability expected to …

Read More »